Sullivan, J., Scheffer, I. E., Lagae, L., Nabbout, R., Pringsheim, M., Talwar, D., . . . Farfel, G. (2020). Fenfluramine HCl (Fintepla(®)) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study. Epilepsia.
Chicago Style citaatSullivan, Joseph, et al. "Fenfluramine HCl (Fintepla(®)) Provides Long‐term Clinically Meaningful Reduction in Seizure Frequency: Analysis of an Ongoing Open‐label Extension Study." Epilepsia 2020.
MLA citatieSullivan, Joseph, et al. "Fenfluramine HCl (Fintepla(®)) Provides Long‐term Clinically Meaningful Reduction in Seizure Frequency: Analysis of an Ongoing Open‐label Extension Study." Epilepsia 2020.
Let op: Deze citaties zijn niet altijd 100% accuraat.